Jemimah Corpuz
Optometrist · Seattle, WANPI 1962947978
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 244 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 21 manufacturers reported payments, led by Mallinckrodt Hospital Products Inc. at 25.4% of the total. Among optometrist clinicians in WA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 244 payments — averaging $30.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Mallinckrodt Hospital Products Inc.$2K
- Sun Pharmaceutical Industries Inc.$982
- Johnson & Johnson Vision Care, Inc.$754
- AbbVie$552
- Bausch & Lomb Americas Inc.$454
- Mallinckrodt Enterprises LLC$438
- plus $2K from 15 others
What the payments were for
- Food & beverage$7,514100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Mallinckrodt Hospital Products Inc. | 58 | $1,909 |
| Sun Pharmaceutical Industries Inc. | 34 | $982 |
| Johnson & Johnson Vision Care, Inc. | 50 | $754 |
| AbbVie(2 entities) | 17 | $552 |
| Bausch & Lomb Americas Inc. | 10 | $454 |
| Mallinckrodt Enterprises LLC | 16 | $438 |
| Oyster Point Pharma, Inc. | 9 | $398 |
| Eyevance Pharmaceuticals LLC | 2 | $286 |
| Dompe US, Inc. | 7 | $265 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 14 | $239 |
| Biotissue Holdings Inc. | 2 | $206 |
| Glaukos Corporation | 1 | $169 |
| Tarsus Pharmaceuticals, Inc. | 2 | $150 |
| Kala Pharmaceuticals, Inc. | 3 | $145 |
| Coopervision Inc. | 2 | $140 |
| Novartis | 9 | $136 |
| ANI Pharmaceuticals, Inc. | 1 | $127 |
| Alcon | 3 | $67 |
| Katena Products, Inc. (dba Corza Medical) | 2 | $55 |
| Thea Pharma Inc. | 1 | $21 |
| Shire North American Group Inc | 1 | $20 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ACTHAR$1,034
- Flarex$273
- CEQUA$255
- Photrexa Viscous and Photrexa$169
- Acuvue$161
- TYRVAYA$149
- INFUSE$148
- PURIFIED CORTROPHIN GEL$127
- Oxervate$126
- XDEMVY$125
- MIEBO$123
- MiSight Contact Lens$120
- VUITY$119
- EYSUVIS$106
How this compares
$7,514 in reported general payments places this provider in the 95th percentile of 1,267 optometrist providers in Washington.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| RestasisCyclosporine | 14 | $12,540 |
| XiidraLifitegrast | 11 | $10,141 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieRestasis | $552 | $12,54014 claims |
| Bausch & Lomb Americas Inc.Xiidra | $454 | $10,14111 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,267 optometrist providers in Washington.
Other optometrist in Seattle
- Roya HabibiSeattle$109K
- Anita LamSeattle$30K
- Huy HoangSeattle$11K
- Sathi MaitiSeattle$7K
- Leslie LungSeattle$7K
- Gregory ChinSeattle$6K
- Leigh KimSeattle$6K
- Steve BirdSeattle$5K
- Kerri SvandaSeattle$5K
- David KadingKirkland$397K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.